Search Results

You are looking at 1 - 10 of 260 items for :

  • cardiovascular risk x
Clear All
Open access

Andrea V Haas, Paul N Hopkins, Nancy J Brown, Luminita H Pojoga, Jonathan S Williams, Gail K Adler and Gordon H Williams

mounting evidence that CV risk is heritable ( 20 ). Members of our group have previously shown that a prevalent caveolin-1 (CAV1) gene variant (rs926198) is related to cardiovascular risk (insulin resistance and the metabolic syndrome) ( 21 , 22 ). CAV1 is

Open access

David J F Smith, Hemanth Prabhudev, Sirazum Choudhury and Karim Meeran

crises, whereas excessive replacement puts patients at the risk of Cushingoid symptoms and cardiovascular disease ( 6 , 7 ). In an attempt to mimic circadian rhythmicity, hydrocortisone analogues have been developed, including dual release hydrocortisone

Open access

Gunjan Garg, Garima Kachhawa, Rekha Ramot, Rajesh Khadgawat, Nikhil Tandon, V Sreenivas, Alka Kriplani and N Gupta

cardiovascular risk factors in subjects with PCOS. Material and methods Study design This study was conducted as a prospective randomized double-blind placebo controlled study after obtaining approval from the ethics committee of the institute and written

Open access

Katica Bajuk Studen and Marija Pfeifer

, impaired glucose tolerance or frank type 2 diabetes, low-grade inflammation and increased pro-thrombotic state ( 2 ). This high prevalence of cardiovascular risk factors in PCOS is assumed to be associated with accelerated cardiovascular disease. However

Open access

Jens P Goetze, Linda M Hilsted, Jens F Rehfeld and Urban Alehagen

as a Kaplan–Meier analysis were used to analyze the risk of mortality during the follow-up period. Censored patients were those still alive at end of the study period or who had died of other causes than cardiovascular disease. Completed patients

Open access

Enrique Soto-Pedre, Paul J Newey, John S Bevan and Graham P Leese

hyperprolactinaemia may be associated with heart valve disease (including that related to the use of dopamine agonist therapy), cardiovascular risk factors or cardiovascular mortality ( 4 , 5 , 6 , 7 ). Results from epidemiologic studies that have examined the

Open access

Vito Francic, Martin Keppel, Verena Schwetz, Christian Trummer, Marlene Pandis, Valentin Borzan, Martin R Grübler, Nicolas D Verheyen, Marcus E Kleber, Graciela Delgado, Angela P Moissl, Benjamin Dieplinger, Winfried März, Andreas Tomaschitz, Stefan Pilz and Barbara Obermayer-Pietsch

complex phenomenon ( 1 ). Indeed, according to population-based and epidemiological studies, cardiovascular events are more common in winter, which coincides not only with lower temperatures and with the peak of several cardiovascular risk factors as well

Open access

Huguette S Brink, Aart Jan van der Lely and Joke van der Linden

obesity and T2DM ( 7 , 8 ). Long-term maternal risks include T2DM and cardiovascular disease ( 9 ). Currently, the GD diagnosis is made during the late second trimester, possibly exposing the infant to intrauterine metabolic alterations and epigenetic

Open access

Kristin Godang, Karolina Lundstam, Charlotte Mollerup, Stine Lyngvi Fougner, Ylva Pernow, Jörgen Nordenström, Thord Rosén, Svante Jansson, Mikael Hellström, Jens Bollerslev, Ansgar Heck and the SIPH Study Group

cardiovascular disease ( 2 , 3 ). PTH is a metabolically active hormone and elevated levels of PTH are associated with alterations in cardiac structure and function, cardiovascular risk factors and overweight ( 4 , 5 , 6 , 7 ). Some studies, but not all, have

Open access

Johan Verhelst, Anders F Mattsson, Cecilia Camacho-Hübner, Anton Luger and Roger Abs

, 3 , 4 ). MetS describes the clustering of five cardiovascular risk factors: increased waist circumference due to visceral fat accumulation, elevated blood pressure, lowered HDL cholesterol, increased triglycerides, and impaired glucose tolerance and